Cipla Q4 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,638.45
-13.45 (-0.81%)
-13.45 (-0.81%)Volume28.22 K
Updated: Thu 19 Sep, 2024 | 15:54:15
NSE
1,637.7-13.90 (-0.84%)
-13.90 (-0.84%)Volume2.05 M
Updated: Thu 19 Sep, 2024 | 15:44:25
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Cipla Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 6,163.24 | 5,810.09 | -6.67% | 5,739.30 | 7.39% |
| Selling/ General/ Admin Expenses Total | 1,084.23 | 948.69 | 1.51% | 964.84 | 12.37% |
| Depreciation/ Amortization | 288.34 | 272.11 | 23.52% | 346.22 | -16.72% |
| Other Operating Expenses Total | 1,713.03 | 1,449.55 | 9.21% | 1,537.35 | 11.43% |
| Total Operating Expense | 5,135.72 | 4,674.65 | -2.82% | 5,094.20 | 0.82% |
| Operating Income | 1,027.52 | 1,135.44 | -22.12% | 645.10 | 59.28% |
| Net Income Before Taxes | 1,259.26 | 1,218.06 | -14.56% | 745.37 | 68.94% |
| Net Income | 939.04 | 800.96 | -11.07% | 525.65 | 78.64% |
| Diluted Normalized EPS | 11.62 | 9.92 | -21.58% | 8.10 | 43.52% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Arkade Developers IPO Day 4: GMP, subscription status, review. Apply or not?
3 min read19 Sep 2024 - Markets
02Northern Arc Capital IPO Day 4: GMP, key dates, subscription status to review. Should you apply or not?
5 min read08:26 AM IST - Markets
03Western Carriers IPO: GMP, subscription status to review. Should you apply as bidding ends today?
3 min read19 Sep 2024